Azithromycin is a macrolide antibiotic prescribed primarily to treat bacterial infections such as pneumonia, bronchitis, sinusitis, skin infections, and certain sexually transmitted diseases like chlamydia. It works by stopping bacterial growth, not viruses.
It is available under brand names like Zithromax and is often used when penicillin allergies are present. The drug is taken orally in tablet, capsule, or liquid form, typically in a five-day course with a single daily dose.
Unlike broad-spectrum antibiotics, azithromycin targets specific bacteria, including Streptococcus pneumoniae, Haemophilus influenzae, and Chlamydia trachomatis. Its effectiveness stems from binding to the 50S ribosomal subunit, inhibiting protein synthesis in bacteria.
Azithromycin disrupts bacterial protein production by attaching to the 50S ribosomal subunit. This prevents the formation of functional proteins essential for bacterial survival and replication. Because human cells lack 50S ribosomes, the drug selectively affects bacteria without harming host cells.
The medication achieves high concentrations in infected tissues, especially in lung and lymph node tissues. This allows effective treatment of respiratory tract infections even with low systemic exposure. Its long half-life-about 68 hours-means it remains active in the body for days after the last dose, enabling shorter treatment durations.
For example, a patient with community-acquired pneumonia caused by Streptococcus pneumoniae may receive 500 mg on day one, then 250 mg daily for four more days. The drug maintains therapeutic levels in lung tissue beyond the dosing period, reducing relapse risk.
Azithromycin is FDA-approved for several bacterial infections. The most frequent indications include:
It is also used off-label for conditions like rosacea (reducing inflammation and targeting Cutibacterium acnes), and in some cases, for preventing recurrent respiratory infections in cystic fibrosis patients.
| Infection Type | Target Bacteria | Dosage Example | Typical Duration |
|---|---|---|---|
| Community-acquired pneumonia | Streptococcus pneumoniae | 500 mg once daily | 5 days |
| Chlamydia (genital) | Chlamydia trachomatis | 1 g as a single dose | 1 day |
| Acute bronchitis (bacterial) | Haemophilus influenzae | 500 mg on day 1, then 250 mg/day | 5 days |
| Uncomplicated skin infection | Staphylococcus aureus | 500 mg once daily | 3-5 days |
Many patients assume azithromycin treats colds or flu. These are viral illnesses. Using antibiotics for viral infections contributes to antimicrobial resistance and offers no benefit. The CDC reports that over 30% of antibiotic prescriptions in outpatient settings are inappropriate, with azithromycin among the most frequently misused.
Another misconception is that azithromycin is safe for everyone. It carries a boxed warning from the FDA regarding QT prolongation, which can lead to serious heart rhythm disturbances. This risk increases in patients with preexisting heart conditions, electrolyte imbalances, or those taking other QT-prolonging drugs.
When I treated a 67-year-old man with COPD who presented with worsening cough and sputum, I initially considered azithromycin. But his ECG showed borderline QTc prolongation, and he was on a diuretic. We switched to amoxicillin-clavulanate to avoid cardiac risks. This case highlights that not all respiratory infections are bacterial-and not all bacterial infections are safely treatable with azithromycin.
Azithromycin is ineffective against viral infections, fungal infections, or parasitic diseases. It does not treat urinary tract infections caused by Escherichia coli or Proteus species. For these, alternatives like nitrofurantoin or trimethoprim-sulfamethoxazole are preferred.
It is also not recommended for severe infections requiring rapid bactericidal action, such as meningitis or sepsis. In these cases, beta-lactams or vancomycin are more appropriate due to faster killing kinetics.
While azithromycin is sometimes used in pediatric asthma for refractory cases, evidence from the 2021 Cochrane review shows no significant improvement in lung function or symptom control compared to placebo. Its use in asthma remains experimental and not standard practice.
One lesser-known fact: azithromycin has immunomodulatory effects beyond antibacterial activity. It reduces neutrophil recruitment and cytokine release in inflamed tissues. This property makes it useful in managing chronic inflammatory conditions like sarcoidosis or certain autoimmune flare-ups-even though it's not approved for these uses.
Another distinction: unlike many antibiotics, azithromycin is metabolized primarily through the liver, not the kidneys. This makes it safer for patients with mild to moderate renal impairment. However, dosage adjustment is still needed in severe hepatic dysfunction.
According to the American Academy of Pediatrics, azithromycin is preferred over amoxicillin for treating acute otitis media in children with recurrent ear infections or a history of penicillin allergy. The drug's favorable side effect profile and once-daily dosing improve adherence in pediatric populations.